These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 22116087)

  • 1. The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.
    Walker LS; Sansom DM
    Nat Rev Immunol; 2011 Nov; 11(12):852-63. PubMed ID: 22116087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of T cell activation by CD28 and CTLA4.
    Noel PJ; Boise LH; Thompson CB
    Adv Exp Med Biol; 1996; 406():209-17. PubMed ID: 8910687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells.
    Wang CJ; Kenefeck R; Wardzinski L; Attridge K; Manzotti C; Schmidt EM; Qureshi OS; Sansom DM; Walker LS
    J Immunol; 2012 Aug; 189(3):1118-22. PubMed ID: 22753931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The B7-independent isoform of CTLA-4 functions to regulate autoimmune diabetes.
    Stumpf M; Zhou X; Bluestone JA
    J Immunol; 2013 Feb; 190(3):961-9. PubMed ID: 23293354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models.
    Shin JH; Park HB; Oh YM; Lim DP; Lee JE; Seo HH; Lee SJ; Eom HS; Kim IH; Lee SH; Choi K
    Blood; 2012 Jun; 119(24):5678-87. PubMed ID: 22538857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFIS Lecture: Understanding the CTLA-4 checkpoint in the maintenance of immune homeostasis.
    Walker LSK
    Immunol Lett; 2017 Apr; 184():43-50. PubMed ID: 28216262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28.
    Fallarino F; Fields PE; Gajewski TF
    J Exp Med; 1998 Jul; 188(1):205-10. PubMed ID: 9653097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
    J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.
    Wing K; Yamaguchi T; Sakaguchi S
    Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of Autoimmune Thyroiditis by CTLA-4 Blockade: A Role for IFNγ-Induced Indoleamine 2, 3-Dioxygenase.
    Sharma R; Di Dalmazi G; Caturegli P
    Thyroid; 2016 Aug; 26(8):1117-24. PubMed ID: 27296629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.
    Marangoni F; Zhang R; Mani V; Thelen M; Ali Akbar NJ; Warner RD; Äijö T; Zappulli V; Martinez GJ; Turka LA; Mempel TR
    J Immunol; 2018 May; 200(10):3647-3661. PubMed ID: 29661826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease.
    Chang TT; Kuchroo VK; Sharpe AH
    Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754
    [No Abstract]   [Full Text] [Related]  

  • 14. The soluble isoform of CTLA-4 as a regulator of T-cell responses.
    Ward FJ; Dahal LN; Wijesekera SK; Abdul-Jawad SK; Kaewarpai T; Xu H; Vickers MA; Barker RN
    Eur J Immunol; 2013 May; 43(5):1274-85. PubMed ID: 23400950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal.
    Lu Y; Schneider H; Rudd CE
    Blood; 2012 Nov; 120(23):4560-70. PubMed ID: 23047820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
    Paterson AM; Lovitch SB; Sage PT; Juneja VR; Lee Y; Trombley JD; Arancibia-Cárcamo CV; Sobel RA; Rudensky AY; Kuchroo VK; Freeman GJ; Sharpe AH
    J Exp Med; 2015 Sep; 212(10):1603-21. PubMed ID: 26371185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What did we learn from CTLA-4 insufficiency on the human immune system?
    Mitsuiki N; Schwab C; Grimbacher B
    Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.
    Hou TZ; Qureshi OS; Wang CJ; Baker J; Young SP; Walker LS; Sansom DM
    J Immunol; 2015 Mar; 194(5):2148-59. PubMed ID: 25632005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of co-inhibitory signals driven by CTLA-4 in immune system].
    Olive D; le Thi S; Xerri L; Hirsch I; Nunès JA
    Med Sci (Paris); 2011 Oct; 27(10):842-9. PubMed ID: 22027421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ups and downs of T cell costimulation.
    Jenkins MK
    Immunity; 1994 Sep; 1(6):443-6. PubMed ID: 7534615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 36.